Drug firm GlaxoSmithKline Pharmaceuticals Monday reported a 26 per cent rise in its standalone net profit at Rs 112.97 crore for the quarter ended December 31, 2018, mainly on account of one-time gain of Rs 28 crore.
The company had posted a net profit of Rs 89.69 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.
Standalone revenue from operations of the company stood at Rs 825.35 crore for the quarter under consideration as against Rs 703.91 crore for the same period a year ago.
Commenting on the results, GlaxoSmithKline Pharmaceuticals MD A Vaidheesh said, "The business embarked on its new strategy this year, as we put in place an optimal commercial structure and worked at building capability."
Exceptional items for the quarter ended December 31, 2018, comprise profit from sale of property of Rs 23 crore and non-core brand divestments contributing Rs 5 crore."
Disclaimer: No Business Standard Journalist was involved in creation of this content